Dyadic International Inc (DYAI)
1.14
+0.02
(+1.79%)
USD |
NASDAQ |
Nov 14, 16:00
1.14
0.00 (0.00%)
After-Hours: 18:31
Dyadic International Enterprise Value: 28.37M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 28.37M |
| November 12, 2024 | 28.96M |
| November 11, 2024 | 26.30M |
| November 08, 2024 | 28.96M |
| November 07, 2024 | 27.48M |
| November 06, 2024 | 26.60M |
| November 05, 2024 | 26.30M |
| November 04, 2024 | 26.30M |
| November 01, 2024 | 26.60M |
| October 31, 2024 | 26.60M |
| October 30, 2024 | 26.30M |
| October 29, 2024 | 26.89M |
| October 28, 2024 | 27.45M |
| October 25, 2024 | 26.60M |
| October 24, 2024 | 28.01M |
| October 23, 2024 | 27.78M |
| October 22, 2024 | 28.66M |
| October 21, 2024 | 28.07M |
| October 18, 2024 | 29.57M |
| October 17, 2024 | 28.66M |
| October 16, 2024 | 29.55M |
| October 15, 2024 | 27.19M |
| October 14, 2024 | 26.30M |
| October 11, 2024 | 28.37M |
| October 10, 2024 | 29.28M |
| Date | Value |
|---|---|
| October 09, 2024 | 28.66M |
| October 08, 2024 | 30.14M |
| October 07, 2024 | 27.48M |
| October 04, 2024 | 24.83M |
| October 03, 2024 | 24.39M |
| October 02, 2024 | 25.72M |
| October 01, 2024 | 25.72M |
| September 30, 2024 | 26.01M |
| September 27, 2024 | 27.78M |
| September 26, 2024 | 27.34M |
| September 25, 2024 | 28.66M |
| September 24, 2024 | 27.78M |
| September 23, 2024 | 30.73M |
| September 20, 2024 | 32.20M |
| September 19, 2024 | 30.43M |
| September 18, 2024 | 29.55M |
| September 17, 2024 | 32.20M |
| September 16, 2024 | 31.61M |
| September 13, 2024 | 31.91M |
| September 12, 2024 | 31.91M |
| September 11, 2024 | 32.20M |
| September 10, 2024 | 33.67M |
| September 09, 2024 | 31.91M |
| September 06, 2024 | 32.49M |
| September 05, 2024 | 32.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
19.50M
Minimum
Dec 13 2022
250.55M
Maximum
Jun 22 2020
80.29M
Average
64.06M
Median
Jul 26 2022
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 7.900M |
| Perspective Therapeutics Inc | 378.39M |
| Protalix BioTherapeutics Inc | 66.58M |
| Electromed Inc | 224.00M |
| Armata Pharmaceuticals Inc | 183.40M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.045M |
| Revenue (Quarterly) | 0.3859M |
| Total Expenses (Quarterly) | 2.425M |
| EPS Diluted (Quarterly) | -0.07 |
| Gross Profit Margin (Quarterly) | 21.75% |
| Profit Margin (Quarterly) | -530.0% |
| Earnings Yield | -24.56% |
| Normalized Earnings Yield | -27.78 |